Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00276289 · ClinicalTrials.gov registry record · NA
Spironolactone to Decrease Potassium Wasting in Hypercalciurics on Thiazides Diuretics
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00276289 is a NA study that has completed, run by Indiana University. The registered enrollment target is 10 participants.
The verdict
NCT00276289, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Kidney stone formation due to an excess of calcium in the urine is a common problem. It is treated with thiazide diuretics. These drugs often cause excessively low blood potassium levels that in turn require large doses of potassium supplements. These supplements are often large, unpleasant and easy to forget. We are trying the addition of spironolactone to these patients' medications to see if it allows them to take a lower dose of potassium.
Interventions
- DRUG Spironolactone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2006-01 |
| Est. Completion | 2006-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00276289
The ClinicalTrials.gov registry entry for NCT00276289 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Spironolactone is the first listed.
NCT00276289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00276289 about?
NCT00276289 is a clinical study titled "Spironolactone to Decrease Potassium Wasting in Hypercalciurics on Thiazides Diuretics". Kidney stone formation due to an excess of calcium in the urine is a common problem. It is treated with thiazide diuretics. These drugs often cause excessively low blood potassium levels that in turn require large doses of potassium supplements. These supplements are often large, unpleasant and easy...
What is the current status of trial NCT00276289?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2006-01. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00276289?
The interventions under investigation include: Spironolactone (DRUG).
Who is sponsoring clinical trial NCT00276289?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.